Company / Current Assets per Share
ALNYLAM PHARMACEUTICALS, INC. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$31.33
FY2025
5-year range
$22.40 / $31.33
FY2021-FY2025
Trend
+19.6%
vs FY2024
Sector context
#17 of 210
Health Care
What the data says
Among 210 Health Care companies, ALNYLAM PHARMACEUTICALS, INC. is in the top 8% for current assets per share. Current Assets per Share has increased for 3 consecutive years, from $22.40 in FY2022 to $31.33 in FY2025.
Based on SEC 10-K filings.
31.33 in FY2025 with a 5-year CAGR of +6.1%. Top quartile in the Health Care sector.
Improved from $24.07 to $31.33 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +11.8%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
-76.7% below sector average
Key checks
Key Insights
- ALNYLAM PHARMACEUTICALS, INC.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 19.6% year-over-year.
- Ranks #17 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.33 | +19.6% |
| FY2024 | $26.20 | +8.8% |
| FY2023 | $24.07 | +7.4% |
| FY2022 | $22.40 | -7.1% |
| FY2021 | $24.12 | +3.5% |
| FY2020 | $23.31 | +37.4% |
| FY2019 | $16.96 | +40.8% |
| FY2018 | $12.05 | -38.2% |
| FY2017 | $19.49 | +148.3% |
| FY2016 | $7.85 | -40.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026